Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ward

Showing results (1301-1310 of 1,525) with videos related to

Pageof 153
Sort By:
Nature Communications|September 26, 2015
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spikeJeong Hyun Lee, Daniel P Leaman, Arthur S Kim, et al.
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
Cell Reports|July 9, 2025
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic <i>E. coli adhesin</i>Zachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Journal of Rehabilitation Medicine|February 7, 2009
European consensus table on the use of botulinum toxin type A in adult spasticityJörg Wissel, Anthony B Ward, Per Erztgaard, et al.
Nature Medicine|May 15, 2020
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.
Immunity|November 23, 2017
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody LineageElise Landais, Ben Murrell, Bryan Briney, et al.
Pageof 153

Showing results (1301-1310 of 1,525) with videos related to

Sort By:
Pageof 153
Nature Communications|September 26, 2015
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spikeJeong Hyun Lee, Daniel P Leaman, Arthur S Kim, et al.
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
Cell Reports|July 9, 2025
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic <i>E. coli adhesin</i>Zachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Journal of Rehabilitation Medicine|February 7, 2009
European consensus table on the use of botulinum toxin type A in adult spasticityJörg Wissel, Anthony B Ward, Per Erztgaard, et al.
Nature Medicine|May 15, 2020
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.
Immunity|November 23, 2017
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody LineageElise Landais, Ben Murrell, Bryan Briney, et al.
Pageof 153